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ABSTRACT
Objective To determine whether dietary intervention or
knee strengthening exercise, or both, can reduce knee
pain and improve knee function in overweight and obese
adults in the community.
Design Pragmatic factorial randomised controlled trial.
Setting Five general practices in Nottingham.
Participants389menandwomenaged45andoverwitha
body mass index (BMI) of ≥28.0 and self reported knee
pain.
Interventions Participants were randomised to dietary
intervention plus quadriceps strengthening exercises;
dietary intervention alone; quadriceps strengthening
exercises alone; advice leaflet only (control group).
Dietary intervention consisted of individualised healthy
eating advice that would reduce normal intake by 2.5 MJ
(600 kcal) a day. Interventions were delivered at home
visits over a two year period.
Main outcome measures The primary outcome was
severity of knee pain scored with the Western Ontario
McMaster (WOMAC) osteoarthritis index at 6, 12, and
24 months. Secondary outcomes (all at 24 months)
included WOMAC knee physical function and stiffness
scores and selected domains on the SF-36 and the
hospital anxiety and depression index.
Results289(74%)participantscompletedthetrial.There
was a significant reduction in knee pain in the knee
exercise groups compared with those in the non-exercise
groups at 24 months (percentage risk difference 11.61,
95%confidence interval1.81%to 21.41%).Theabsolute
effect size (0.25) was moderate. The number needed to
treat to benefit from a ≥30% improvement in knee pain at
24 months was 9 (5 to 55). In those randomised to knee
exercise improvement in function was evident at
24 months (mean difference −3.64, −6.01 to −1.27). The
meandifferenceinweightlossat24monthsinthedietary
intervention group compared with no dietary intervention
was2.95kg(1.44to4.46);forexerciseversusnoexercise
thedifferencewas0.43kg(−0.82to1.68).Thisdifference
in weight loss was not associated with improvement in
kneepainorfunctionbutwasassociatedwithareduction
in depression (absolute effect size 0.19).
Conclusions A home based, self managed programme of
simple knee strengthening exercises over a two year
period can significantly reduce knee pain and improve
knee function in overweight and obese people with knee
pain.Amoderatesustainedweightlossisachievablewith
dietary intervention and is associated with reduced
depression but is without apparent influence on pain or
function.
Trial registration Current Controlled Trials ISRCTN
93206785.
INTRODUCTION
Kneepainisamajorcauseofdisabilityandisespecially
prevalentinthoseagedover50.Muchofthiskneepain
is caused by osteoarthritis, the most common form of
joint disease and a leading cause of lower limb disabil-
ityinolderpeople.
1Asystematicreviewofkneepainin
older adults reported that during a one year period, a
quarter of people aged over 55 have an episode of per-
sistent knee pain, around half of whom report asso-
ciated disability.
1 About 4.5 million people aged over
50intheUnitedKingdomareestimatedtohavesevere
problemsfromkneepain,andthisfigureislikelytorise
dramatically as the proportion of the population aged
50oroverincreases.Becauseofitsconsiderablehealth
impact, regional knee pain has been described as the
“new back pain.”
2
Obesity is an established risk factor for the develop-
ment and progression of both structural knee
osteoarthritis
3-6 and knee pain.
7 It usually predates the
development of knee osteoarthritis, supporting cause
rather than consequence.
8 The burden of knee pain is
expected to increase with the increasing prevalence of
obesity,projectedtobeabout35%intheUKby2015.
9
An estimated quarter to half of all knee osteoarthritis
might be prevented by eliminating obesity.
10 Knee
osteoarthritis is therefore an increasingly important
public health problem with respect to time lost from
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valence of clinically severe osteoarthritis.
11
All international recommendations emphasise the
central role of non-pharmacological management of
kneepainandosteoarthritis.
12-15Thereissufficientevi-
dence to recommend weight reduction as an inter-
vention for knee osteoarthritis
1617 and convincing
evidence, including a recent systematic review, that
exercise (both aerobic and muscle strengthening)
reduces pain and disability from knee
osteoarthritis.
18-21 Weight loss can also reduce the risk
of knee osteoarthritis
22 and, together with an exercise
programme, improve knee function.
23 Only one ran-
domised trial (in the United States) has assessed the
effect of weight loss and exercise specifically in over-
weight and obese people with knee osteoarthritis.
24
That trial reported that the combination of modest
weight loss plus moderate exercise provides better
overall improvements in self reported measures of
functionandpaininolderoverweightandobeseadults
with knee osteoarthritis compared with either inter-
vention alone.
We used a pragmatic, open, factorial randomised
controlled trial to determine whether individualised
interventions of diet and quadriceps strengthening
exercisereducekneepainincommunityderivedover-
weight and obese adults aged 45 and over. We also
examined the effects of these interventions on knee
stiffness, physical function, and quality of life. A sec-
ondary objective was to determine whether it was pos-
sible to identify at baseline those individuals most
likely to comply and therefore benefit from the inter-
ventions by using two simple questions that assess
“willingness to change,” lifestyle, and dietary beha-
viour.
METHODS
Recruitment of participants
All men and women aged 45 and over with a body
mass index (BMI) of ≥28.0 and knee pain who were
registered at one of five general practices in Notting-
ham were eligible for inclusion. In addition, a small
number of people were recruited after publicity in
localmedia.Exclusioncriteriawererheumatoidarthri-
tis, cardiac pacemaker, intra-articular injection of ster-
oid into either knee within past three months, lower
limb amputation, total knee replacement, unable to
complete recruitment questionnaire, unable to under-
take either intervention, unwilling to take part.
To ascertain eligible people in the community, each
generalpracticesenta postalquestionnairetoallregis-
tered patients aged 45 and older. There was no upper
agelimit.Questionnaireswerenotsenttoterminallyill
patients or those with psychiatric illness, dementia, or
other incapacitating disease deemed by their general
practitionertomakethemunsuitableforparticipation.
Thequestionnairewasdesignedtoassessdemographic
details, general health, frequency of knee pain, use of
analgesics, physical activity, and attitudes to dietary
and lifestyle changes. It incorporated the SF-36,
25 the
hospital anxiety and depressionrating scale,
26 and two
questionsonhowwillingtheyweretochangetheirlife-
style and diet.
27 People with knee pain were defined as
those who reported having knee pain on most days of
the past month. We did not include those with recent
onsetacutepainrelatedtoobvioustrauma.Completed
questionnaires were returned in pre-paid envelopes to
the trial centre at the University of Nottingham. The
trial coordinator telephoned respondents with knee
painwhowereoverweightorobeseandwhoindicated
willingness to receive further information. During this
callthetrialwasexplained,anyquerieswereanswered,
and the coordinator checked that the person met the
eligibility criteria (stated above) and that they were
interested in taking part. An information pack includ-
ingapreliminaryconsentformandreplyenvelopewas
then sent out. The study was also publicised via local
media (press and radio).
Randomisation procedure
Participants aged 45 or more with a measured BMI
≥28.0 and knee pain were randomised to one of four
groups: dietary intervention plus quadriceps strength-
eningexercises;dietaryinterventionalone;quadriceps
strengthening exercises alone; and advice leaflet only
(control group). Random allocation to one of the four
treatment groups was based on the 2 × 2 factorial
design with a computer generated list, in permuted
blocks of 10, stratified by sex, age (<65, ≥65), and
BMI (<40, ≥40). Because we expected that more peo-
ple would withdraw from the dietary intervention
groups than the exercise groups, randomisation
favoured the dietary intervention groups by a ratio of
3:2toallowforfutureplannedexploratoryanalyses.A
trial researcher prepared the allocation sequence lists,
which were kept in a locked drawer. The trial coordi-
nator carried out the allocation. On receipt of a signed
preliminary consent form, the coordinator consulted
the appropriate allocation sequence list and assigned
the participant to the next treatment group number
on that list according to the participant’s sex, age, and
BMI. The participant was then telephoned to notify
them of their group and the first visit booked. All par-
ticipants were allocated to a treatment group before
their first visit. Informed consent was obtained at the
firstvisit.This wasan opentrial;by necessitytheparti-
cipantsandthosedeliveringtheinterventionswerenot
blind to allocation.
Interventions
All participants in the dietary groups completed the
EPIC seven day food diary
28 before the first home
visitbythetrialdietitian.Thedietaryinterventioncon-
sisted of individualised dietary advice that would help
tocreateadeficitof2.5MJ(600kcal)aday,inlinewith
healthy eating recommendations (reducing fat and
sugar intake, eating more fruit and vegetables, and
reducing portion size) and achieve a weight loss of
0.5-1.0 kg a week. The dietitian, the dietetic assistant,
or a research interviewer carried out follow-up home
visits. If there were questions that could not be
addressed by the researcher at the visit, the dietitian
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ephone as soon as possible after the visit. Newsletters
from the dietitian containing recipe ideas and advice
for eating healthily when eating out or at holiday
times were sent every few months. Occasionally, the
EPICseven day fooddiary wasusedagain to ascertain
participants’ eating habits before a visit.
For participants randomised to the diet and exercise
group the trial dietitian also taught the programme of
exercises at the initial home visit. The exercise pro-
gramme comprised a series of simple exercises in five
sections, primarily designed to strengthen the quadri-
ceps muscle, as used in our previous trials.
2021
Although participants received initial instruction in
performing the exercises, exercises were subsequently
undertaken at home, unsupervised, and with minimal
contact with the research visitor and therefore were
predominantly self managed. Section A comprised
simple flexibility exercises such as extension and flex-
ion of the ankle while the person was seated on the
floor or bed. Section B comprised gentle (unresisted)
strengthening exercises to start building up the knee
muscles—for example, sitting on the floor with both
legs out in front, toes pointed towards the ceiling,
with a towel roll beneath one knee to bend it slightly.
Thekneeispushedintothefloorsothatthethighmus-
cle tightens. Section C comprised resisted exercises
incorporating graded elastic bands, designed to give
the thigh muscles more work. After two months, sec-
tion D exercises were introduced. These were func-
tional exercises, such as rising from the sitting
position, designed to help with everyday tasks. After
about six months into the programme, participants
were asked to attempt section E (aerobic) exercises
such as walking and stepping up and down a step. Par-
ticipants were asked to work through the sections one
at a time, at their own pace, doing at least two of the
exerciseseachday.Theywereaskedtorepeattheexer-
cises five times, building up to a maximum of 20 for
each leg and to record the number and type of exer-
cises carried out each day in their exercise diary. The
advice leaflet was based on the Arthritis Research
Campaign (UK) leaflet for osteoarthritis of the knee,
but we removed information related to the inter-
vention regimens.
Participants in the dietary groups were visited at
home once a month for the first six months and then
everyothermonthforthedurationofthe24monthsof
follow-up.Thoseintheexerciseonlyorcontrolgroups
were visited every four months throughout the
24 months but received a support telephone call in
between their visits. These calls were not used to rein-
force the exercise programme. At each visit, partici-
pants were asked about their knee pain, their general
health, their medications, and their levels of physical
activity.Allparticipantswereweighedateachvisit.We
endeavoured to arrange that the same researcher vis-
ited a participant throughout the trial, although this
was not always possible. Visits were conducted in the
evening if necessary.
X ray characterisation
All participants underwent knee radiography within
the firstfewmonthsofstartingthe trial.Posterior-ante-
rior weight bearing knee radiographs were taken with
the SynaFlex x ray positioning frame (Synarc, San
Francisco, CA
29), with feet externally rotated 10° and
knees and thighs touching the vertical platform ante-
riorly and the x ray beam angled 10° caudally. Skyline
30° views of both patellofemoral compartments were
takenwiththeparticipantintheseatedpositionandthe
beamangledfromfeettoknees.Asingletrainedobser-
ver (MD), who was blinded to the intervention group,
read the radiographs. Severity of tibiofemoral osteoar-
thritis was scored (0-4) with the Kellgren-Lawrence
gradingscale.
30Severityofindividualfeatures(narrow-
ing −1-3, osteophyte 0-3) in each of the three compart-
ments(medialandlateraltibiofemoral,patellofemoral)
of each knee were graded with the Nottingham logi-
cally derived line drawing atlas (LDLDA),
31 which
uses different narrowing scales for men and women
to allow for normally thicker cartilage width in men.
Using this scale, we classified tibiofemoral osteoarthri-
tis as grade 2 narrowing plus grade 2 osteophyte in
either tibiofemoral compartment of at least one knee,
and patellofemoral osteoarthritis as grade 2 narrowing
plus grade 2 osteophyte in at least one patellofemoral
joint. Because of the advantages of the line drawing
atlas over the Kellgren-Lawrence scale, we used this
system to classify definitive radiographic osteoarthri-
tis.
Outcomes
The primary outcome was a “response” defined as a
reduction in pain score from baseline of ≥30% at
24 months with knee pain severity scored with the
pain subscale of the Western Ontario and McMaster
Universities (WOMAC) osteoarthritis index.
32 We
compared mean knee pain scores at 6, 12, and
24monthsbetweentreatmentarmsasasecondaryout-
come. Additional secondary outcome measures, ana-
lysed at 24 months only, comprised mean change in
WOMAC stiffness subscale, WOMAC physical func-
tion subscale, hospital anxiety and depression rating
scale,andmeanchangeinthebodilypainandphysical
function domains of the SF-36. All outcome question-
naires were posted to participants and were self com-
pleted. They were either given to the researcher at the
nextvisitorreturnedinpre-paidenvelopes.Wherever
possible, participants who had missed questions were
telephoned.
We also asked participants to complete a brief ques-
tionnaireattheendofthetrialtoascertaintheiruseand
dose of analgesics during the trial compared with
before the trial.
Statistical analysis
A factorial design allowed examination of two inter-
ventions. We had four treatment groups: (1) dietary
intervention + quadriceps strengthening exercises;
(2) dietary intervention only; (3) quadriceps strength-
ening exercises only; and (4) advice leaflet. We were
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+4)andexercise(1+3v2+4)withrespecttothemean
change in WOMAC primary and secondary out-
comes, hence we analysed the data collected using an
at-the-margins approach (a main effects approach). At
the outset of the trial, we did not anticipate an inter-
action between diet and exercise.
Weaimedtorecruit400participants.Areductionin
pain score of 50% or more from baseline to 24 months
was defined as a successful outcome, and success rates
in the control and intervention arms were assumed to
be 20% and 40%, respectively. At a trial steering com-
mittee meeting (and before recruitment ended), how-
ever, we decided to change the definition to 30% or
moretoreflectamoreappropriateoutcomeforacom-
munity derived population with self reported knee
pain (without changing the assumed event rates).
Incontrastwithusualpracticeweinflatedthesample
sizetopermitadequatepowerfortwoexploratoryana-
lyses: an assessment of the success of the dietary inter-
vention on knee pain in those prospectively identified
as “willing to change” and comply with the inter-
vention, which, based on our previous work, would
be 50%-70% of participants, and an assessment of the
effectofdietaryinterventioninthosewithradiographic
evidence of disease (estimated to be present in about
half of overweight people). Furthermore, to allow for
potentially greater withdrawal in the dietary inter-
vention group, we aimed to randomise 160 to receive
the advice leaflet and 240 to receive the dietary inter-
ventionbutequalnumberstoexerciseandnoexercise.
This resulted in the unusually high power of >98% for
both primary comparisons.
Analyses adopted the intention to treat principle,
with all participants analysed “as randomised” after
multiple imputation for missing data.
3334 Multiple
imputationwasperformedwiththemethodofchained
equationsandfivesetsofimputations,asimplemented
intheStataiceadd-on.
35Thesetsofpredictorvariables
for the missing valueswere determined in an objective
manner with the pred_eq add-on.
36 Imputations were
performed separately for each treatment arm with the
common set of predictor variables, which permitted
inclusion of the response itself. Within each imputed
dataset, we dichotomised the imputed pain at
24 months in accordance with the definition of a
response (final pain score <70% of baseline). A sensi-
tivity analysis, in which we assumed that missing out-
comedatawerenotmissingatrandom,wasperformed
for the primary outcome. For different fractions of
thoseparticipantsforwhomtheoutcomewasimputed,
the imputed value was replaced by one in the less
favourable direction. This was repeated five times
and the treatment effect and 95% confidence intervals
averaged.
Each analysis of the primary and secondary out-
comes included the stratification variables of age, sex,
BMI, and baseline outcome as covariates as well as
indicators for each intervention (diet and knee
strengthening exercise) to calculate estimates of the
risk difference and change in mean outcome values.
The primary analysis also tested the diet by exercise
interaction (at a 10% significance level).
The risk differenceswere estimated by a generalised
linear model with the binomial family, identity link,
and robust standard error. We combined the resulting
estimates with Rubin’s rule by the mim prefix,
37 and
obtained a covariate adjusted number needed to treat
for benefit and approximate 95% confidence limits as
the reciprocal of the risk difference and its confidence
limits.
The time course of treatment effects was estimated
byalinearmodelincorporatingtime×treatmentinter-
actions and presented as fitted differences in mean
WOMAC pain score, with 95% confidence intervals,
at 6, 12, and 24 months. Secondary outcomes at
24 months are presented as differences in mean
WOMAC stiffness, WOMAC physical function, hos-
pital anxiety and depression, and SF-36 subscales of
bodily pain and physical function, with 95% confi-
dence intervals.
Postal questionnaire (n=12 448)
Randomised (n=389)
Returned blank
questionnaire (n=298)
Potentially eligible from
postal questionnaire:
BMI ≥28.0 and
knee pain (n=728)
No response
(n=4404)
Ineligible:
BMI <28.0 and/or no
knee pain (n=7018)
Not willing (n=122):
  Did not return initial consent
    form (n=102)
  Unable to contact (n=10)
Did not meet further inclusion criteria (assessed by
  telephone) (n=105):
    Total knee replacement (n=29)
   Rheumatoid arthritis (n=21)
   No telephone (n=15)
   Partner eligible (n=14)
   Steroid injection (n=7)
   Pacemaker (n=2)
   Other (n=17)
Leaflet
(n=76)
Exercise only
(n=82)
Diet only
(n=122)
Diet + exercise
(n=109)
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o
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t
h
s Responders (n=69)
Non-responders:
  In trial (n=5)
  Withdrawn (n=2)
Responders (n=66)
Non-responders:
  In trial (n=9)
  Withdrawn (n=5)
  Excluded (n=2)
Responders (n=109)
Non-responders:
  In trial (n=7)
  Withdrawn (n=3)
  Excluded (n=3)
Responders (n=94)
Non-responders:
  In trial (n=3)
  Withdrawn (n=6)
  Excluded (n=6)
1
2
 
m
o
n
t
h
s Responders (n=68)
Non-responders:
  In trial (n=4)
  Withdrawn (n=3)
  Excluded (n=1)
Responders (n=63)
Non-responders:
  In trial (n=5)
  Withdrawn (n=10)
  Excluded (n=4)
Responders (n=106)
Non-responders:
  In trial (n=8)
  Withdrawn (n=4)
  Excluded (n=4)
Responders (n=84)
Non-responders:
  In trial (n=8)
  Withdrawn (n=10)
  Excluded (n=7)
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m
o
n
t
h
s Responders (n=65)
Non-responders:
  In trial (n=1)
  Withdrawn (n=5)
  Excluded (n=5)
Responders (n=61)
Non-responders:
  In trial (n=1)
  Withdrawn (n=15)
  Excluded (n=5)
Responders (n=104)
Non-responders:
  In trial (n=3)
  Withdrawn (n=6)
  Excluded (n=9)
Responders (n=86)
Non-responders:
  In trial (n=2)
  Withdrawn (n=14)
  Excluded (n=7)
Flow of participants through trial. All those randomised contribute to multiple imputation to
follow intention to treat principle. Responders are those returning an outcome. Responders at
24 months contribute to complete case analysis. In each treatment group, categories at each
time point are not mutually exclusive as some people who withdrew, returned an outcome
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interactions, using the baseline thirds of age, BMI,
WOMAC pain, and Kellgren-Lawrence osteoarthritis
grade. The treatment effect in the top third was com-
pared with that in the lower two thirds in each inter-
action test. These subgroup analyses were limited to
the primary outcome at 24 months.
External validity was assessed by comparing the
demographic characteristics of participants with those
oftheeligiblepeoplewhowerenotrandomised(thatis,
those who did not return the initial consent form after
receiving the information pack). Summary descriptive
statistics, analysis of compliance, “willingness to
change,” and analgesic use was performed with SPSS,
while all of the above analyses were performed with
Stata (version 10.0), and carried out according to a
predefined analysis plan. An independent steering
committee and a data monitoring committee moni-
tored the trial. No interim analyses were performed
during the study period. Service use and cost implica-
tions were examined in an economic evaluation car-
ried out as part of this trial, the results of which are in
an accompanying paper (BMJ doi:10.1136/bmj.
b2273).
RESULTS
Recruitment began in May 2003 and ended in March
2005.ThelastparticipantcompletedthetrialinFebru-
ary 2007. The figure shows a summary of recruitment.
Of the 728 men and women who had knee pain and a
BMI≥28.0,122(17%)werenotwillingtotakepart,105
(14%) did not meet the further inclusion criteria when
telephoned,and10(1%)couldnotbecontacted.Infor-
mation packs were sent to 491 people (67%), of whom
389 returned an initial consent form and were rando-
mised: 109 to dietary intervention and quadriceps
strengthening exercises, 122 to dietary intervention
only, 82 to quadriceps strengthening exercises only,
and 76 to advice leaflet (control group). Of these parti-
cipants, 69 (18%) were recruited via local media and
not directly from a general practice. Participants who
returned outcome questionnaires at the different time
points and the status of those with unknown outcome
(non-responders)aredepictedintheflowchart(figure).
There was no significant difference with respect to age
or BMI between participants and eligible non-partici-
pants (the 102 people who received information packs
but did not return a consent form). There were, how-
ever, significantly more women in the participant
group (66% v 57%). Two hundred and eighty four
(73%) completed the trial. Over 3700 home visits
took place.
Table 1 shows the baseline characteristics of partici-
pants, which were similar between the groups (mean
age 61, median BMI 33.6, 66% women). Most partici-
pants (351, 90%) had knee radiography within the first
fewweeks,47%ofwhichshowedsignsofosteoarthritis
(Kellgren-Lawrence scale ≥2). According to the Not-
tingham logically derived line drawing atlas, 57 (16%)
had isolated tibiofemoral osteoarthritis, 35 (10%) had
isolated patellofemoral osteoarthritis, and 14 (4%) had
both.
Over the course of the trial, 74 participants (19%)
withdrew (table 2), most because of personal or medi-
cal problems, family commitments, and lack of time.
Thirteenofthesedidnotreceivetheallocationbecause
they cancelled their first visit. Withdrawals occurred
moreofteninthefirstsixmonthsandweresignificantly
greater from the exercise groups, 52 (27%) than from
the non-exercise groups, 21 (11%)). We excluded 26
(7%) participants (table 2) because they had a total
knee replacement (n=13), could not be contacted for
further visits (n=7), exhibited inappropriate behaviour
at a home visit (n=2), were considered too frail at first
visit to undertake intervention (n=2), needed steroid
injections (n=1), or had died (n=1). Four of those
excluded did not receive the allocation.
Table 1 |Baseline characteristics of participants by treatment group. Figures are numbers
(percentages) of participants unless stated otherwise
Characteristics
Diet + exercise
(n=109)
Diet only
(n=122)
Exercise only
(n=82)
Leaflet only
(n=76)
Mean (SD) age (years) 61.1 (9.2) 61.7 (9.2) 61.1 (9.8) 61.5 (9.2)
W o m e n 7 3( 6 7 ) 7 9( 6 5 ) 5 6( 6 8 ) 4 9( 6 5 )
Median (IQR) weight (kg) 91.4 (17.8) 93.4 (17.3) 92.2 (21.8) 94.2 (20.2)
Mean (SD) height (m) 1.65 (0.09) 1.65 (0.09) 1.64 (0.10) 1.66 (0.10)
Median (IQR) BMI 33.0 (5.9) 33.6 (4.6) 34.8 (6.6) 33.0 (6.5)
Kellgren-Lawrence score*:
0 4 1( 4 5 ) 5 6( 5 0 ) 3 5( 4 7 ) 2 7( 3 7 )
1 7 (8) 5 (4) 6 (8) 9 (12)
2 16 (18) 13 (12) 8 (11) 9 (12)
3 13 (14) 20 (18) 8 (11) 12 (16)
4 1 4( 1 5 ) 1 9( 1 7 ) 1 7( 2 3 ) 1 6( 2 2 )
Nottingham LDLDA*:
Isolated tibiofemoral OA 13 (14) 19 (17) 13 (18) 12 (16)
Isolated patellofemoral OA 8 (9) 9 (8) 10 (14) 8 (11)
Tibiofemoral + patellofemoral OA 3 (3) 3 (3) 4 (5) 4 (6)
No definitive OA 67 (74) 82 (73) 47 (64) 49 (67)
Use of painkillers:
Never/occasionally 54 (50) 53 (44) 39 (48) 38 (50)
Regularly 53 (50) 68 (56) 43 (52) 38 (50)
Comorbidities:
Heart disease 12 (11) 23 (19) 9 (11) 10 (13)
Asthma 12 (11) 19 (16) 9 (11) 13 (17)
Cancer 5 (5) 7 (6) 1 (1) 5 (7)
Diabetes 10 (9) 12 (10) 7 (9) 6 (8)
Osteoarthritis (self reported) 50 (46) 50 (41) 26 (32) 25 (33)
BMI category†:
Overweight 17 (17) 15 (13) 10 (13) 14 (19)
O b e s ec l a s sI 5 1( 5 0 ) 6 2( 5 2 ) 3 3( 4 2 ) 3 0( 4 1 )
Obese class II 23 (22) 32 (27) 25 (32) 21 (29)
Morbidly obese 12 (12) 11 (9) 10 (13) 8 (11)
Mean (SD) WOMAC‡:
Pain (range 0-20) 8.03 (3.25) 8.07 (4.03) 7.61 (3.14) 7.32 (3.41)
Stiffness (range 0-8) 3.99 (1.55) 4.03 (1.59) 3.78 (1.53) 3.79 (1.62)
Physical function (range 0-68) 28.46 (12.85) 29.01 (13.90) 27.09 (11.24) 26.26 (12.33)
IQR=interquartile range; BMI=body mass index; LDLDA=logically derived line drawing atlas; OA=osteoarthritis;
WOMAC=Western Ontario McMaster osteoarthritis index.
*351/389 attended for x ray investigation.
†Weight at first visit, some participants withdrew before first visit, some were excluded before or at first visit.
‡Highest score=greatest pain, stiffness, dysfunction.
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24 months was 94, 84, and 86 (86%, 77%, and 79%)
for the diet and exercise group; 109, 106, and 104
(89%, 87%, and 85%) for the diet only group; 66, 63,
and 61 (81%, 77%, and 74%) for the exercise only
group; and 69, 68, and 65 (91%, 90%, and 86%) for
the advice leaflet group. In a main effects analysis, we
compared those randomised to knee strengthening
exercise with those not randomised to exercise (all
exercise v all non-exercise), likewise, we compared
those randomised to the dietary intervention with
those not randomised to it (all diet v all non-diet).
There was no evidence of an interaction between diet
and exercise (estimated coefficient =−0.084, 95% con-
fidence interval −0.28 to 0.12; P=0.407).
Primary outcome
At 24 months, 38 (47%) of the exercise only group
achieved ≥30% reduction in pain from baseline com-
pared with 23 (30%) of the advice leaflet group. Mean
pain scoreswere 5.70 and 7.04, respectively (estimates
numbersofsuccessesincludevaluesbasedonmultiple
imputation) (table 3).
Table 4 shows the estimates of risk difference for
improvement in WOMAC pain score at 24 months.
The risk difference corresponds to a good response,
defined as a ≥30% reduction in pain from baseline.
After multiple imputation, there was a significant
reduction in knee pain in the knee exercise groups
compared with the the non-exercise groups at
24 months (percentage risk difference 11.61, 95% con-
fidence interval 1.81% to 21.41%). This represents an
absolute benefit of 11.6 percentage points and corre-
sponds to the number needed to treat with knee exer-
cise for such a benefit (at 24 months) of 9 (5 to 55),
adjusted for dietary intervention, age, BMI, sex, and
baseline pain score. Those exposed to knee exercise
were more likely to experience a ≥30% reduction in
pain (relative risk 1.36, 1.05 to 1.76; P=0.022). The
absoluteeffectsize(0.25)isonlyjustwithinthe moder-
aterange.Therewasnoevidenceofaneffectofdietary
intervention on pain. Table 4 also shows the similarity
oftheriskdifferences(forexercise)whenweusedcom-
plete case and per protocol analysis. In this trial “per
protocol” refers to analysis of outcome assessments of
all those who completed the trial and who were not
excluded or did not withdraw. Table 5 summarises
the time course of treatment effects. Improvement in
themeanWOMACpainscorewasevidentintheexer-
cise group at 6 months, not evident at 12 months, and
significantat24months,witha nettreatmenteffect(all
exercise minus all non-exercise) of −0.91 (−1.66 to
−0.17; P=0.016). There was no evidence of an effect
of dietary intervention over time on the WOMAC
pain score (table 5). The sensitivity analysis for the
missing at random assumption showed that using lin-
ear interpolation, the 95% lower confidence limit for
exercise would just be zero if 34% of the imputed
responses for pain at 24 months were in fact in the
lessfavourabledirection.Weregardthisasbeingmod-
erately sensitive to the missing at random assumption.
Secondary outcomes
Table6showsthemeanchangesinWOMACphysical
function and knee stiffness scores at 24 months. There
wasamaintreatmenteffectofkneestrengtheningexer-
cisewithasignificantnetreductioninthemeanchange
in WOMAC physical function score (−3.64, −6.01 to
−1.27; P=0.003) and stiffness (−0.35, −0.66 to −0.03;
P=0.030). The absolute effect sizes were 0.24 and
0.19, respectively. There was no evidence of an effect
of dietary intervention on these WOMAC outcomes.
Analysis of the quality of life outcome data at
24 months (table 6) showed a significant effect of exer-
cise,withimprovementsintheSF-36subscalesofbod-
ily pain and physical function (absolute effect size for
each is 0.22). There was no evidence of an effect of
dietary intervention on these secondary outcomes,
buttherewasareductioninthedepressionscore(abso-
lute effect size=0.19).
Analysis of the pre-specified binary subgroups (age,
BMI,WOMACpain,andKellgren-Lawrenceosteoar-
thritis grade), with a test for interaction and a signifi-
cance level of P<0.10, did not show any differences in
intervention effect across these subgroups (table 7),
exceptforexerciseandBMI(P=0.061).Wealsoexam-
ined mean weight loss at 24 months. The difference in
Table 2 |Reasons for withdrawal and exclusion by treatment group. Figures are numbers
(percentages of group)
Diet + exercise Diet only Exercise only Leaflet
Reason for withdrawal:
Changed mind 5 (5) 7 (6) 7 (9) 2 (3)
Too busy 9 (8) 5 (4) 5 (6) 0
Personal 8 (7) 0 6 (7) 1 (1)
Medical 4 (4) 1 (1) 6 (7) 3 (4)
Other 1 (1) 1 (1) 2 (2) 1 (1)
Total 27 (25) 14 (11) 26 (32) 7 (9)
Reason for exclusion*:
TKR 2 (2) 6 (5) 2 (2) 3 (4)
Unable to contact 2 (2) 3 (2) 0 2 (3)
Unsuitable for treatment 2 (2) 0 0 0
Inappropriate behaviour 1 (1) 0 1 (1) 0
Steroid injection 0 0 1 (1) 0
Died 0 0 1 (1) 0
Total 7 (6) 9 (7) 5 (6) 5 (7)
TKR=total knee replacement.
*Only excluded for per protocol analysis.
Table 3 |Percentage with successful outcome and mean WOMAC pain score at 24 months by
treatment group
Treatment
No
of participants*
No (%) with successful
outcome†
Mean (SD)
pain score‡
Advice leaflet 76 23 (30) 7.04 (4.21)
Diet only 122 42 (35) 6.96 (4.33)
Exercise only 82 38 (47) 5.70 (3.96)
Diet + exercise 109 46 (43) 6.39 (4.15)
*As randomised.
†≥30% reduction in pain score. Numbers with successful outcome include those derived from imputation.
‡Unadjusted for covariates, but allowing for multiple imputation.
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between the dietary and non-dietary groups was 2.95
kg (1.44 to 4.46; P=0.000). Therewas a non-significant
differenceinmeanweightlossofonly0.43kg(−0.82to
1.68; P=0.501) between the exercise group and those
not exposed to this intervention. These data are
adjusted for treatment, age, BMI, sex, and baseline
weight. Per protocol analysis with SPSS showed that
the dietary intervention was successful; those in the
dietary groups (diet + exercise and diet only) being
twice as likely to experience moderate weight loss
(5% of initial weight) compared with non-dietary
groups (exercise only + advice leaflet only) at
24 months (unadjusted relative risk 2.3, 1.42 to 3.74;
P<0.001). Knee strengthening exercise was not asso-
ciated with moderate weight loss (results not shown).
Compliance
We were not able to measure direct compliance with
the dietary intervention but all participants were
weighed at each visit. Compliance with exercise was
graded as high or low according to how well the exer-
cise diaries had been completed. They were cate-
gorised by a single observer who made a global
judgment of all exercise diaries with some adjustment
for pattern of regularity. In the diet + exercise group
and the exercise only group, 49 (45%) and 37 (45%),
respectively, complied highly with the exercise pro-
gramme for 24 months. Those with high compliance
were more likely to have a baseline WOMAC pain
score above the top third (>9.0) and were more likely
to be women.
Comparedwithbeforestartingthetrial,selfreported
use of analgesics (for knee pain) and dose during the
trialwerebothsignificantlylowerintheexercisegroup
than in the non-exercise group. Significantly fewer
people in the exercise group reported having had
knee pain on most days of the past month of the trial.
There were no significant differences in the distribu-
tionofresponsestothesequestionswhenwecompared
the dietary group with the non-dietary group (results
not shown). A participant’s willingness to change their
lifestyleortheirdiet,categorisedfromresponsesinthe
ascertainment questionnaire (and thus before the start
of the trial), was not associated with exercise compli-
ance, pain improvement of ≥30%, or with loss of ≥5%
of initial body weight.
DISCUSSION
In overweight and obese adults aged 45 and over, a
simple home based knee strengthening exercise pro-
gramme reduced knee pain, improved the function of
the knee, and reduced knee stiffness over a two year
period. These effects were not apparent in people allo-
cated to a dietary intervention alone, even though
weight loss was achieved, but levels of depression
were reduced.
Comparison with other studies
Our results add to the substantial evidence, sum-
marised in a recent overview of nine systematic
reviews,
38 that exercise interventions for patients with
knee osteoarthritis reduce pain and improve physical
function but that effect sizes are considered small.
Another systematic review and meta-analysis of four
randomised controlled trials of weight reduction in
obese patients with knee osteoarthritis concluded that
there is robust evidence that weight reduction
improves self reported disability and reduces pain,
though only self reported disability and not pain
could be predicted by weight loss.
39 Comparison with
otherstudiesisdifficultbecauseofthediversityintreat-
ment regimens and follow-up periods. We found no
evidence of an effect of dietary intervention on knee
pain or function. In the review by Christensen et al,
39
threeofthe four trialsreportingpainasanexplicit out-
come showed a significant weight loss in the inter-
vention group, but the pooled mean weight loss (6.1
kg) was higher than that experienced by our dietary
participants (2.9 kg at 24 months). The follow-up in
these three studies was shorter (8 weeks, 6 months,
18 months) and participants had a higher mean base-
line BMI. Post hoc calculations from data from one of
the trials in this review also showed that clinical effi-
cacy could be shown only when weight loss is added
to an exercise treatment. The weighted pooled effect
size from these three studies was small (0.20) so it is
possible that the moderate long term weight loss in
our trial was not sufficient to affect pain.
Table 4 |Risk difference estimates for WOMAC pain at 24 months
Treatment
Risk difference* (%)
P value Mean (SE) 95% CI
Multiple imputation (n=389):
Exercise v no exercise 11.61 (4.99) 1.81 to 21.41 0.020
Diet v no diet −0.08 (5.70) −11.44 to 11.27 0.988
Complete case (n=316):
Exercise v no exercise 13.18 (5.51) 2.37 to 23.98 0.017
Diet v no diet −0.24 (5.59) −11.20 to 10.72 0.966
Per protocol (n=284):
Exercise v no exercise 12.93 (5.88) 1.41 to 24.45 0.028
Diet v no diet 1.68 (5.90) −13.25 to 9.89 0.776
*Adjusted for age, sex, body mass index (BMI), baseline pain, and indicators for each intervention.
Table 5 |Differences in mean WOMAC pain scores by time
Time (months)
Difference*
P value Mean (SE) 95% CI
Exercise v no exercise
6 −0.76 (0.39) −1.53 to 0.01 0.052
12 −0.52 (0.41) −1.33 to 0.28 0.202
24 −0.91 (0.38) −1.66 to −0.17 0.016
Diet v no diet
6 0.06 (0.40) −0.75 to 0.86 0.887
12 0.14 (0.38) −0.60 to 0.89 0.705
24 −0.08 (0.41) −0.91 to 0.75 0.849
*Analysis after multiple imputation and adjusted for other intervention plus exercise × time, diet × time, BMI
band, age band, baseline pain, and sex.
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cantly improved the quality of life outcomes of SF-36
physical function and bodily pain. SF-36 measure-
ments sometimes produce different results from those
oftheprimaryefficacyoutcomesbutrarelymodifythe
overall interpretation of randomised trials.
40 This con-
cordance strengthens our WOMAC primary and sec-
ondaryoutcomeconclusions.Dietaryinterventionwas
not associated with these quality of life outcomes but
did seem to reduce the depression score, which sug-
gests that obesity is associated with a lower health
related quality of life, a result also found in an analysis
of 1865patients registeredat onegeneral practicewho
completedtheascertainmentquestionnaireusedinthis
trial.
41 That paper reported that relative to a normal
BMI,obesitywasassociatedwithalowerhealthrelated
quality of life after adjustment for patients’ character-
istics and comorbidities.
41 A positive association
between BMI and depression was recently reported
in a large cohort of primary care patients with
osteoarthritis,
42 and a recent review of the impact of
obesity on the musculoskeletal system concluded that
obesity was responsible for impaired quality of life.
43
Strengths and limitations
This was a pragmatic trial and the factors that improve
externalvalidity—forexample,noupperageorweight
limit and ascertainment based on knee pain and not
radiographic change—might have reduced the effect
size. A relatively long follow-up period might have
reduced efficacy. Also, contact time with the
researcher was limited to a visit once every four
months for those in the exercise only group (a maxi-
mum of only seven support visits) and exercise
participants were responsible for the management of
their exercise programme, factors that will not have
enhanced adherence. Withdrawals were higher from
the exercise groups than the dietary intervention
group, and the potential selective loss might have
resulted in some bias. We attempted to address this in
our sensitivity analysis. The most common reasons
given for exercise withdrawal were “too busy” and
“personal.” Because only 45% of the exercise partici-
pants complied highly with their programme, our
effects might be underestimated. We could not pro-
duce a more finely graded measure of compliance
becauseofthewiderangeinageandweightandability
to perform the exercises. Thus someone in their late
70s who did only a few exercises every other day was
deemed equivalent (with respect to compliance) to a
younger more active participant performing more
exercises more often.
The fact that the complete case, per protocol, and
multiple imputation analyses all give reasonably simi-
lar results for the primary outcome must at least partly
reflect the low fraction of missing information and is
reassuring. This reassurance, however, cannot be pre-
dicted a priori and neither can the fraction of missing
information,so in general,multiple imputation should
become routine practice. Given that it is rare for a sen-
sitivity analysis to be done at all, our procedure is
admittedly ad hoc. Both the choice of criterion for
assessing sensitivity to “missing at random” and its
interpretationare clearlysubjective. Wechoseasa cri-
terion whether the declaration of significance would
have been affected, but an alternative might be the
extent to which the point estimate of the parameter
wasalteredbychangingassumptions.Ratherthanper-
formasensitivityanalysisitisalsopossibletoexplicitly
model the process by which missing data arise in a
selection model, but we chose not to do this because
this is problematic when covariates have missing
values; the regression coefficients for the response
might be seriously biased if the model is incorrect,
and it is not possible to test such models formally in
any case.
Wedidnotaskparticipantstostoptakingpainkillers
during this relatively long trial, a factor that has the
potential to confound the pain outcomes, but we
Table 7 |Subgroup treatment effect interactions
Interaction
term
Coefficient*
(SE) 95% CI P value
Diet × age 0.085 (0.11) −0.13 to 0.30 0.448
Exercise × age −0.002 (0.11) −0.22 to 0.22 0.986
Diet × BMI −0.032 (0.11) −0.24 to 0.18 0.762
Exercise × BMI −0.206 (0.11) −0.42 to 0.01 0.061
Diet × pain 0.081 (0.13) −0.17 to 0.33 0.518
Exercise × pain −0.042 (0.11) −0.27 to 0.18 0.716
Diet × KL −0.052 (0.11) −0.27 to 0.17 0.639
Exercise × KL −0.097 (0.12) −0.34 to 0.15 0.432
BMI=body mass index, KL=Kellgren-Lawrence osteoarthritis score.
*Analyses included age band, sex, BMI category, and outcome of interest
as covariates plus indicators for each intervention.
Table 6 |Differences in mean change in secondary outcome scores at 24 months
Difference*
P value Mean (SE) 95% CI
WOMAC physical function
Exercise −3.64 (1.21) −6.01 to −1.27 0.003
Diet −2.84 (1.48) −5.88 to 0.19 0.065
WOMAC stiffness
Exercise −0.35 (0.16) −0.66 to −0.03 0.030
Diet −0.16 (0.17) −0.50 to 0.19 0.365
HADS anxiety
Exercise −0.26 (0.37) −1.02 to 0.51 0.496
Diet 0.09 (0.35) −0.62 to 0.79 0.807
HADS depression
Exercise 0.15 (0.37) −0.62 to 0.92 0.693
Diet −0.67 (0.32) −1.30 to −0.04 0.037
SF-36: bodily pain† †
Exercise 5.62 (2.35) 0.99 to 10.25 0.018
Diet 0.94 (2.83) −4.89 to 6.78 0.742
SF-36: physical function† †
Exercise 5.32 (2.04) 1.30 to 9.33 0.010
Diet 3.93 (2.68) −1.64 to 9.49 0.157
*Analyses included age, sex, BMI, and baseline outcome of interest as covariates plus indicators for each
intervention.
†Positive values reflect improvement.
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would have hindered recruitment. There were no dif-
ferences between the four randomisation groups with
respect to self reported use of analgesics at the start of
thetrial,butthoseexposedtoexercisereportedlessuse
and lower doses during the trial than those in the diet-
ary group, facts that support the result of a beneficial
effect from exercise but not from dietary intervention
on pain.
We were interested in seeing whether we could pre-
dict at baseline those who were willing to change their
behaviour,information that might perhapsaid recruit-
mentinfuturestudies.Withthetwoquestionsweused,
however, we were not able to do this. Reasons might
have been respondents’ varying interpretations of the
word “lifestyle” and not connecting this to exercise or
dietary behaviour (these questions were asked before
potential participants knew anything about the trial).
It is clear that regular exercise that strengthens the
thigh(quadriceps)musclescanreducepainanddisabil-
ity from knee pain and osteoarthritis. Such exercise
might act by reducing the muscle weakness and
impaired balance that occurs with knee pain and
osteoarthritis, thus directly improving the stability
and health of the affected knee. This allows people to
do more with their knee and to experience less pain.
Conclusions and policy implications
This large randomised controlled clinical trial investi-
gated the contribution of quadriceps strengthening
exerciseandweight lossonknee pain andfunctionspe-
cifically in an overweight and obese population with
knee pain.A special featureis the use ofmultiple impu-
tationtoaddress the issue ofmissingdataand the inclu-
sion of a sensitivity analysis. These data also show that
long term weight loss through caloric restriction can be
achieved in such a population. Our results give strong
support to published recommendations,
12-17 including
from NICE,
15 for the management of people with
knee osteoarthritis and suggest that clinicians can pre-
scribe knee strengthening exercises and diet for their
overweight and obese patients with knee pain. It also
underlines the need for breaking the vicious circle of
increase in body weight-decrease in physical activity-
increase in osteoarthritis related pain and depression.
Treating comorbidity such as depression might have
a beneficial effect on pain and disability from
osteoarthritis.
44 Interestingly, in our study, although
dietary intervention was associated with a reduction in
depressionscore,therewasnosignificantimprovement
in knee pain and disability. Our study might have been
underpowered to show benefit from non-pharmacolo-
gicaltreatmentofcomorbidity,butclearlythereissuffi-
cient justification to treat comorbidity such as obesity
and depression, even without secondary gain with
respect to osteoarthritis.
Our findings support the long term effectiveness of
quadriceps strengthening exercise as an intervention
for knee pain in overweight and obese adults aged 45
and over. Although the effect size is moderate, it com-
pares favourably with drug based approaches to the
long term management of osteoarthritis. We have
also shown that lifestyle interventions have an impact
on the psychological wellbeing and quality of life of
participantsandthattheseoutcomesareasmeaningful
astheclinicalones.Furtherworkisneededtoestablish
factors that might indicate which participants are most
likely to benefit from these interventions and the best
way to deliver them in primary care and in a way that
overweight and obese people will adhere to, as it is the
general practitioner who is the usual care provider for
such patients with knee osteoarthritis or knee pain.
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